About GHO Capital Partners
GHO Capital Partners is a private equity firm founded in 2014. It is primarily based in London, United Kingdom. As of Aug 2026, GHO Capital Partners has a portfolio of 6 companies, comprising 6 funding rounds and 18 acquisitions. In the last 12 months, it has participated in 1 acquisition. The firm primarily invests in companies based in United States and United Kingdom. Its portfolio is spread across a wide range of sectors from Healthcare to Life Sciences. Most recently it acquired stakes in Scientist.com on Sep 16, 2025.
Overall GHO Capital Partners portfolio has seen 4 acquisitions, namely Biocare Medical, BioAgilytix and Quotient Sciences. Partners Group co-invest with GHO Capital Partners, sharing a substantial percentage of its portfolio.
GHO Capital Partners has a team of 34 people, including 13 partners.
Key Metrics
Founded Year
2014
Location
London, United Kingdom
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
GHO Capital Partners' Portfolio
GHO Capital Partners has a portfolio of 6 companies. They have invested in a total of 6 companies. Their most recent investment was in Sterling Pharma Solutions (Seed round) on May 25, 2023. Here are the most recent investments by GHO Capital Partners:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
May 25, 2023 | Seed | 4633 | ||
Dec 01, 2022 | Seed | 2960 | - | |
Dec 09, 2021 | PE | 9150 | - | |
Oct 26, 2021 | PE | 6511 | - |
GHO Capital Partners has acquired 18 companies. Their most recent acquisition was of Scientist.com on Sep 16, 2025. Here are the most recent acquisitions by GHO Capital Partners:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Sep 16, 2025 | Provider of online marketplace offering drug and R&D services, for preclinical drug development services | $43.9M | 2007 | |
Jul 08, 2025 | Image-based technologies for early digital diagnostics in dermatology and aesthetics | - | 1991 | |
Nov 07, 2024 | CDMO focused on drug substance development, analytical, and quality & regulatory compliance services | - | 2002 | |
Nov 08, 2022 | CDMO advancing pharmaceuticals and biologics from development to delivery | - | 2016 |
Here is the portfolio snapshot of GHO Capital Partners:
Investments by Year
The maximum number of investments were made in 2019
Acquisitions by Year
The maximum number of acquisitions were made in 2021
Portfolio by Location
Companies are primarily in United States and United Kingdom
Portfolio by Sector
Companies are primarily in Healthcare
Team profile of GHO Capital Partners
GHO Capital Partners has a team of 34 members including 13 Partners and 7 Principals located in United Kingdom, Canada and 4 more locations. GHO Capital Partners' team does not sit on the board of any company as of now.Here is a list of top team members in GHO Capital Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Chester | - | - | |
Partner | - | - | ||
Partner | - | - | ||
Partner | London | - | ||
Partner | London | - | ||
Partner | London | - | - | |
Partner | Raleigh | - | ||
Partner | United Kingdom | - | ||
Partner | London | - | - | |
Partner | London | - | - | |
Partner | United Kingdom | - |
Co-investors of GHO Capital Partners
Over the past 12 years, one investor has co-invested in GHO Capital Partners's portfolio companies.
- Top Co-investors of GHO Capital Partners: Partners Group entered a company along with GHO Capital Partners.
GHO Capital Partners News
•
GHO Capital Appoints Olav König as Head of Investor RelationsGlobeNewswire•Jul 14, 2026•GHO Capital Partners
•
Agilent Completes Acquisition Of Biocare MedicalPulse 2.0•Jun 27, 2026•Biocare Medical, Agilent, Excellere, GHO Capital Partners
•
•
•
GHO and CBC Group to Combine Operations, Creating $21 Billion Healthcare Investment PlatformPrivate Equity Wire•May 20, 2026•CBC Group, GHO Capital Partners
•
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and ...TMC•Mar 09, 2026•Biocare Medical, Agilent, Excellere, GHO Capital Partners and 2 others
•
•
GHO Capital Announces Final Close of Fund IV with over €2.5bnGlobeNewswire•Oct 28, 2025•GHO Capital Partners
•
Lupine to Acquire VISUfarma from GHO CapitalGlobal Legal Chronicle•Oct 02, 2025•Lupin, VISUfarma, GHO Capital Partners
•
